hi opel, the revenue is great, it should contribute to paying for operational costs, and prolong the need to need to do a future CR to some extent in the short to medium term.
How much ‘ahead’ will Wellfully be versus the P&G deal: revenue from P&G deal was ‘profit’ costs incurred covered by P&G, will the current deal surpass that figure ‘after’ cost incurred by WFL?
Market may definitely need to see further deals AND sustainability of this deal and any others in the offering. This in the very competitive field of here today gone tomorrow products.
BOD have a very tough gig to compete against the majors already in this field with huge budgets and distribution networks to support their cause.
IMO, not advice.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable